WAT vs MEDP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

WAT

48.1
AI Score
VS
MEDP Wins

MEDP

60.7
AI Score

Investment Advisor Scores

WAT

48score
Recommendation
HOLD

MEDP

61score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric WAT MEDP Winner
Revenue 1.41B 2.91B WAT
Net Income 245.23M -208.00M MEDP
Net Margin 17.3% -7.1% MEDP
Operating Income 288.33M -134.00M MEDP
ROE 56.5% -1.4% MEDP
ROA 11.9% -0.8% MEDP
Total Assets 2.06B 24.75B WAT
Cash 502.69M 539.00M WAT
Current Ratio 0.73 1.86 WAT

Relative Price Performance (Last 90 Days)

WAT 1M: +7.5% · 3M: +19.6% MEDP 1M: +5.1% · 3M: +9.4%

Current Technical Phase

WAT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.3% over 20 days), RSI 66

RSI (14): 65.9 · Price: $457.47

MEDP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.1% over 20 days), RSI 68

RSI (14): 68.2 · Price: $662.48

Fundamentals Snapshot

Metric WAT MEDP
Market Cap — —
Forward P/E 27.7 34.3
Trailing P/E 112.1 36.5
Revenue (TTM) — —
Revenue Growth 1.1% 0.2%
Gross Margin 0.6% 0.7%
Operating Margin 0.1% 0.2%
EPS 3.95 17.03
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MEDP is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.